SHR-1819 not checked

Hengrui

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
4 active
12 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Seasonal Allergic Rhinitis, Adolescents With Moderate-to-severe Atopic Dermatitis, Prurigo Nodularis, Moderate-to-severe Atopic Dermatitis
Main trialPhase 3
“This study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial aimed at evaluating the efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of SHR-1819 injection in patients with Seasonal Allergic Rhinitis (SAR).”In the company’s words, NCT07688772 on ClinicalTrials.gov

Other drugs for Seasonal Allergic Rhinitis

All 11 drugs for Seasonal Allergic Rhinitis

Coming up4

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials12

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Dec 2026 A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
Phase 3Recruiting Nov 2027 A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
Phase 2/3Recruiting Oct 2028 Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis
Phase 2Active, not recruiting Jun 2027 A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
Phase 3Completed 26 Aug 2026 Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
Phase 2Completed 15 Sep 2023 Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
Phase 2Completed 5 Jun 2025 A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis
Phase 2Completed 1 Dec 2025 A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
Phase 1/2Completed 22 Nov 2025 A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis
Phase 1Completed 10 Dec 2021 A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects
Phase 1Completed 27 Oct 2022 A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Phase 1Completed 26 Jun 2026 A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow SHR-1819

Following is part of Solo: you see every change to SHR-1819 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in